Finally, six of the nine candidate lncRNAs [U62317.4, MAPT antisense RNA 1 (MAPT-AS1), AC115837.2, glutathione reductase and glutamic oxaloacetic transaminase (EGOT), Semaphorin 3B antisense RNA 1 (SEMA3B-AS1), and HOTAIR] were identified as the independent prognostic signature for breast cancer patients (Table 2). The gene discussed is MAPT; the disease is breast cancer.